Inhibitors of human plasmin derived from the kunitz domains
US6953674B2 · kind B2 · utility
22Cited by
32References
56Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2002 |
| Grant date | Oct 11, 2005 |
| Priority date | — |
| Expiry date | Nov 16, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/8114
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features novel polypeptides homologous to the first Kunitz domain (K1) of lipoprotein associated coagulation inhibitor (LACI) that are capable of inhibiting plasmin, and nucleic acids encoding these proteins. The invention also features the use of such polypeptides in diagnostic, therapeutic and clinical methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.